Merck, based in Kenilworth, will pay $830 million to settle investor claims that it misrepresented the safety of Vioxx painkillers before pulling the drug from the market in 2004, the company announced Friday.
Local News from NorthJersey.com, The Record
Fri, 01/15/2016 - 7:02am
Merck, based in Kenilworth, will pay $830 million to settle investor claims that it misrepresented the safety of Vioxx painkillers before pulling the drug from the market in 2004, the company announced Friday.